These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24415490)

  • 1. Kanamycin-furosemide ototoxicity in the mouse cochlea: a 3-dimensional analysis.
    Schmitz HM; Johnson SB; Santi PA
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):666-72. PubMed ID: 24415490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.
    Hirose K; Li SZ; Ohlemiller KK; Ransohoff RM
    J Assoc Res Otolaryngol; 2014 Aug; 15(4):555-70. PubMed ID: 24845404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.
    Hirose K; Sato E
    Hear Res; 2011 Feb; 272(1-2):108-16. PubMed ID: 21044672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an ototoxicity model in the adult CBA/CaJ mouse and determination of a golden window of corticosteroid intervention for otoprotection.
    Fernandes VT; Lin VY
    J Otolaryngol Head Neck Surg; 2014 Apr; 43(1):12. PubMed ID: 24762042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxic effects of the interaction between kanamycin and ethacrynic acid. Cochlear ultrastructure correlated with cochlear potentials and kanamycin levels.
    Russell NJ; Fox KE; Brummett RE
    Acta Otolaryngol; 1979; 88(5-6):369-81. PubMed ID: 532612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the TGF-β signaling exacerbates degeneration of auditory neurons in kanamycin-induced ototoxicity in mice.
    Nitta Y; Kurioka T; Mogi S; Sano H; Yamashita T
    Sci Rep; 2024 May; 14(1):10910. PubMed ID: 38740884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox2 and JAGGED1 expression in normal and drug-damaged adult mouse inner ear.
    Oesterle EC; Campbell S; Taylor RR; Forge A; Hume CR
    J Assoc Res Otolaryngol; 2008 Mar; 9(1):65-89. PubMed ID: 18157569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid.
    Xu SA; Shepherd RK; Chen Y; Clark GM
    Hear Res; 1993 Nov; 70(2):205-15. PubMed ID: 8294265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atoh1 induces auditory hair cell recovery in mice after ototoxic injury.
    Kraft S; Hsu C; Brough DE; Staecker H
    Laryngoscope; 2013 Apr; 123(4):992-9. PubMed ID: 23483451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scar formation in mice deafened with kanamycin and furosemide.
    Żak M; van der Linden CA; Bezdjian A; Hendriksen FG; Klis SF; Grolman W
    Microsc Res Tech; 2016 Aug; 79(8):766-72. PubMed ID: 27311812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of 3', 4'-dideoxykanamycin B and potent diuretics on the cochlea. (A scanning and transmission electron microscopic evaluation).
    Nakai Y
    Laryngoscope; 1977 Sep; 87(9 Pt 1):1548-58. PubMed ID: 895312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-independent pathways of hair cell death induced by kanamycin in vivo.
    Jiang H; Sha SH; Forge A; Schacht J
    Cell Death Differ; 2006 Jan; 13(1):20-30. PubMed ID: 16021180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapid cochlea lesion induced by co-administration of kanamycin and furosemide in mouse].
    Xiong H; Chu HQ; Huang XW; Cui YH; Zhou LQ; Chen J; Li JL; Wang Y; Chen QG; Li ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Mar; 45(3):222-8. PubMed ID: 20450703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Furosemide-induced alteration of drug pathway to cochlea.
    Yamane H; Nakai Y; Konishi K
    Acta Otolaryngol Suppl; 1988; 447():28-35. PubMed ID: 3055805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a model of cochlear lesions in rats to study potential gene therapy for sensorineural hearing loss.
    Wang Y; Qiao L; Chen Y; Wen L; Yue B; Qiu J; Wu S
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2147-54. PubMed ID: 26574172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kanamycin Damages Early Postnatal, but Not Adult Spiral Ganglion Neurons.
    Gao K; Ding D; Sun H; Roth J; Salvi R
    Neurotox Res; 2017 Nov; 32(4):603-613. PubMed ID: 28656549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative ototoxicity of bumetanide and furosemide when used in combination with kanamycin.
    Brummett RE; Bendrick T; Himes D
    J Clin Pharmacol; 1981; 21(11):628-36. PubMed ID: 7338574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxicity of kanamycin sulfate and the barriers in the inner ear.
    Komune S; Snow JB
    Otolaryngol Head Neck Surg; 1981; 89(6):1013-8. PubMed ID: 6801580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural correlates of selective outer hair cell destruction following kanamycin intoxication in the chinchilla.
    Ryan AF; Woolf NK; Bone RC
    Hear Res; 1980 Dec; 3(4):335-51. PubMed ID: 7451380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide.
    Versnel H; Agterberg MJ; de Groot JC; Smoorenburg GF; Klis SF
    Hear Res; 2007 Sep; 231(1-2):1-12. PubMed ID: 17475424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.